Belotero is the latest, most advanced form of dermal filler available today. It has a unique ability to integrate with the tissues of your skin, providing volume and a more youthful shape to your face. Belotero can reduce lines and wrinkles while enhancing your own facial contours.
As we get older, our skin's production of the substances that keep it moisturized and supple begins to slow, resulting in an increase in wrinkles and lines. But Belotero is a dermal filler that incorporates one of these natural substances, hyaluronic acid (HA), to help you achieve smoother, more youthful looking skin once again.
In clinical studies of Belotero, 97 percent of patients showed a visible improvement after a single treatment. Belotero can eliminate even the finest of lines. Belotero injections plump the skin subtly and evenly so patients appear relaxed and refreshed without looking like they have a noticeable implant.
There are different formulations of Belotero available, making it ideal to improve a wide variety of skin issues. This filler can treat frown lines between the eyebrows, periorbital lines (crow's feet), nasolabial folds from the nose to the corners of the mouth, perioral lines and marionette lines from the corners of the mouth to the jaw. In addition, it can round the cheekbones, plump the lips, restore softness to the hands and décolletage and more.
The quick and nearly painless procedure typically takes 20 minutes and most people can return to work immediately afterward. The results of Belotero treatment are not permanent and vary by individual. For most patients, the effects are still visible nine months after an injection. Follow-up treatments are typically done every six to 12 months.
Xeomin is a form of botulinum toxin type A that can be injected into the muscles just beneath the skin to reduce facial lines and wrinkles. Particularly effective in treating deep frown lines between the eyebrows, Xeomin has received FDA approval.
Like other types of botulinum treatments, Xeomin prevents muscles from contracting. However, Xeomin is different from its predecessors in that it contains no additives, which may decrease a patient's antibody reaction. If the immune system is not creating antibodies to fight it, the treatment will be much more successful.
Results of Xeomin treatment are typically evident in one week and last between three and six months.